DMK Pharmaceuticals Corporation
DMK Pharmaceuticals Corporation (DMKPQ) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · DMKPQ · as of Mar 31, 2024
Ownership Breakdown
2
Institutional Holders
▼ 28 vs Q4
$0
Total Inst. Value
▼ $35,284 vs Q4
10.10M
Shares Outstanding
freeFloat 99.80%
67
13F Shares Held
▼ 500,447 vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
DMKPQ largest shareholders · institutional ownership
Q1 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
CLEAR POINT ADVISORS INC. pharmaceutical preparations | 53 | 0.74% | 0.74% | $3,000 | May 16, 2024 | — held |
OLD POINT TRUST & FINANCIAL SERVICES N A pharmaceutical preparations | 14 | 0.20% | 0.20% | $1,000 | May 14, 2024 | NEW |
WELLS FARGO & COMPANY/MN pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 10, 2024 | EXIT |
VANGUARD GROUP INC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 10, 2024 | EXIT |
FMR LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 13, 2024 | EXIT |
HARBOUR INVESTMENTS, INC. pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Jul 22, 2024 | EXIT |
GROUP ONE TRADING, L.P. pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 10, 2024 | EXIT |
MORGAN STANLEY pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Oct 17, 2024 | EXIT |
NORTHERN TRUST CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 14, 2024 | EXIT |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | May 15, 2024 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2024 vs prior quarter
Q1 2024
0
Increased
+0 shares1
New Positions
first time holders0
Decreased
−0 shares28
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
-27
1 new / 28 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
DMKPQ insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
DMK Pharmaceuticals Corporation (DMKPQ) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 0.20%, while retail and public investors account for the remaining 99.80%.
The largest institutional shareholder of DMK Pharmaceuticals Corporation is CLEAR POINT ADVISORS INC., holding approximately 53 shares — equal to 0.74% of outstanding shares — as of March 31, 2024.
A total of 2 institutional investors currently hold DMKPQ stock, with a combined institutional value of approximately $0 as of the most recent 13F filing period.
Frequently asked questions
DMKPQ ownershipDMK Pharmaceuticals Corporation (DMKPQ) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is CLEAR POINT ADVISORS INC. with a 0.74% stake. Company insiders hold 0.20%. Data sourced from SEC Form 13F as of March 31, 2024.